Results 1 to 10 of about 215,713 (138)
Indian Heart Journal, 2022 Hypertensive crises is still a major public health problem, causing end organ damage like myocardial infarction, stroke, and renal failure. Labetalol and nitroglycerine are among the two most commonly used medicine to control the blood pressure, but ...
Ahmad Rizwan, Rehan Ahmad, Mujahid Beg
exaly +5 more sources
Hypertension in Pregnancy, 2023 Aim To compare oral nifedipine and intravenous labetalol in the treatment of acute severe hypertension in pregnancy (SHP). Methods The primary outcomes were the required time to achieve target blood pressure (RTATBP), systolic blood pressure (SBP) and ...
Minghui Ou +4 more
doaj +3 more sources
Journal of Family Medicine and Primary Care, 2023 Hypertensive disorders of pregnancy affect 5% to 10% of all pregnancies globally. The aim of treatment is to bring down blood pressure (BP) quickly and smoothly, which is safe for the mother and baby.
Manika Agarwal +4 more
doaj +2 more sources
Comparative study of the effect of two different doses of intravenous labetalol on the cardiovascular response to endotracheal extubation [PDF]
Journal of Cardiovascular and Thoracic Research, 2023 Introduction: Providing a stable hemodynamic in extubation is important. We aimed to compare the effect of two different doses of intravenous labetalol on the cardiovascular response to endotracheal extubation. Methods: This double-blind randomized trial
Hamidreza Shetabi +3 more
doaj +3 more sources
Journal of Maternal-Fetal and Neonatal Medicine, 2023 Aim: The optimal drug management strategy for severe hypertension during pregnancy remains inconclusive. Some randomized controlled trials found that oral nifedipine was more effective than intravenous labetalol in hypertensive emergencies during ...
Lin Li
exaly +3 more sources
Journal of International Medical Research, 2023 Objectives Current evidence supporting the use of continuous intravenous labetalol for blood pressure (BP) control in neurosurgical patients is limited. This study aims to assess the efficacy and safety of labetalol in neurosurgical patients and identify
Raywat Noiphithak, Vich Yindeedej
exaly +2 more sources
Intravenous labetalol in severe hypertension. [PDF]
British Journal of Clinical Pharmacology, 1982 1 Labetalol was administered by intravenous infusion or by the combination of intravenous bolus injection plus infusion to 15 patients with severe essential hypertension and to one with phaeochromocytoma. 2 With the infusion alone the reduction of arterial pressure was slow to develop and limited in degree, but with the combination of the bolus ...
Dal Palu C +7 more
openaire +4 more sources
Safety of high-dose intravenous labetalol in hypertensive crisis
American Journal of Health-System Pharmacy, 2019 The study assesses the safety of high-dose intravenous (i.v.) labetalol in adults.This is a retrospective administrative record review of 28 hospitals in one health care system, from October 2010 through October 2015. Patients were included if they received 300 mg of i.v. labetalol within a 24-hour period.
Jason Hecht
exaly +3 more sources
Intravenous Labetalol vs Intravenous Clonidine for Attenuation of Haemodynamic Responses during Laryngoscopy and Intubation in Controlled Hypertensive Patients Undergoing General Anaesthesia- A Randomised Clinical Trial [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Laryngoscopy and endotracheal intubation during general anaesthesia are associated with haemodynamic surges which can be detrimental, particularly if there is pre-existing hypertension or cardiovascular disease. Intravenous (i.v.) labetalol,
Vijay Singh +4 more
doaj +1 more source
The effect of intravenous labetalol administration on hemodynamic responses during desflurane inhalation [PDF]
Korean Journal of Anesthesiology, 2012 BackgroundInspired concentrations of desflurane ≥ 1 minimum alveolar anesthetic concentration (MAC) have been related to sympathetic stimulation such as hypertension and tachycardia.
Hyun-Seok Do +3 more
doaj +1 more source